Unsaturated Phosphine Oxides for Modular Antibody Rebridging and Single Reagent Peptide‐Cyclization‐Bioconjugation
Angewandte Chemie International Edition · 2025
DOI: 10.1002/anie.202508656 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2025. Verfasst von Christian E Stieger und 5 weiteren Autor:innen. Beteiligte Einrichtung: Leibniz-Forschungsinstitut für Molekulare Pharmakologie, im Forschungsverbund Berlin e.V. (FMP), Chemical Biology Department, Campus Berlin-Buch, Rob…. Hauptthemen laut MEDLINE: Phosphines, Oxides, Immunoconjugates, Peptides. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungs-gemeinschaft, Leibniz Society.
Abstract (Originalsprache)
Achieving modular, selective and homogeneous protein modifications is of utmost importance for the design of next generation biopharmaceuticals, especially in the context of antibody‐drug conjugates (ADCs). Here, we introduce unsaturated phosphine oxides as versatile triple‐reactive reagents, allowing orthogonal chemoselective bioconjugation schemes. Starting from triethynyl‐phosphine oxide, a variety of functionalized diethynyl‐triazolyl‐phosphine oxides (DTPOs) could be accessed by using Cu I ‐catalyzed azide‐alkyne cycloaddition (CuAAC). We showcase DTPO‐reagents in the fast and selective generation of various highly stable antibody‐conjugates via antibody disulfide rebridging. A highlight from this methodology is the synthesis of a DAR 4 ADC following a modular 2‐step strategy using bioorthogonal tetrazine‐labeling with bicyclo‐[6.1.0]non‐4‐yne (BCN) or trans ‐cyclooctene (TCO) containing payloads. Notably, the DTPO‐rebridged ADC exhibited potent cytotoxicity against Her2 + cancer cells. Moreover, we utilize triethynyl‐phosphine oxide to obtain ethynyl‐ditriazolyl‐phosphine oxides (EDPOs) which enable a unique, single‐reagent peptide‐cyclization‐bioconjugation protocol resulting in functional cyclic peptide‐protein conjugates. Overall, our work provides versatile and powerful chemoselective modalities for the controlled modification of antibodies, peptide‐cyclization and peptide‐protein conjugation, expanding the toolkit for chemical biology and therapeutic development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Leibniz-Forschungsinstitut für Molekulare Pharmakologie, im Forschungsverbund Berlin e.V. (FMP), Chemical Biology Department, Campus Berlin-Buch, Robert-Roessle-Strasse 10, 13125, Berlin, Germany.
- Department of Chemistry, Humboldt-Universität zu Berlin, Brook-Taylor-Strasse 2, 12489, Berlin, Germany.
- Freie Universität Berlin, Institute of Chemistry and Biochemistry, Arnimallee 20, 14195, Berlin, Germany.
ORCID-Profile: Christian P R Hackenberger
Förderung
- Deutsche Forschungs-gemeinschaft
- Leibniz Society
Zitieren
APA
Stieger, C. E., McMillan, A. J., de Geus, M. A. R., Arafiles, J. V. V., Franz, L., & Hackenberger, C. P. R. (2025). Unsaturated Phosphine Oxides for Modular Antibody Rebridging and Single Reagent Peptide‐Cyclization‐Bioconjugation. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202508656
Vancouver
Stieger CE, McMillan AJ, de Geus MAR, Arafiles JVV, Franz L, Hackenberger CPR. Unsaturated Phosphine Oxides for Modular Antibody Rebridging and Single Reagent Peptide‐Cyclization‐Bioconjugation. Angewandte Chemie International Edition. 2025. doi:10.1002/anie.202508656
BibTeX
@article{Stieger2025,
author = {Stieger, Christian E and McMillan, Alastair J and de Geus, Mark A R and Arafiles, Jan Vincent V and Franz, Luise and Hackenberger, Christian P R},
title = {Unsaturated Phosphine Oxides for Modular Antibody Rebridging and Single Reagent Peptide‐Cyclization‐Bioconjugation},
journal = {Angewandte Chemie International Edition},
year = {2025},
doi = {10.1002/anie.202508656}
}
EUVIMED